Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory comparison of pediatric influenza vaccines Agrippal S1, Influvac, and Vaxigrip in children 6 to <36 months
2004-001952-35Phase 4Completed
- Sponsor
- Chiron Corporation
- Start
- Jul 2004
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of influenza vaccine, inactivated, surface antigen and influenza vaccine in influenza (3 arms), sponsored by Chiron Corporation. Primary endpoints: Immunogenicity and Safety and tolerability. Started Jul 2004; status: completed.
02
Drugs
influenza vaccine, inactivated, surface antigeninfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2004-001952-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001952-35.